Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Walter

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
World Journal of Gastroenterology|October 30, 2019
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centresMelissa Frizziero, Xin Wang, Bipasha Chakrabarty, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2020
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Louis de Mestier, Come Lepage, Eric Baudin, et al.
Developmental Cell|August 14, 2020
A Dual Protein-mRNA Localization Screen Reveals Compartmentalized Translation and Widespread Co-translational RNA TargetingRacha Chouaib, Adham Safieddine, Xavier Pichon, et al.
Neuroendocrinology|February 3, 2017
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)Guillaume Roquin, Eric Baudin, Catherine Lombard-Bohas, et al.
Molecular Cell|October 5, 2024
Cell-cycle-dependent mRNA localization in P-bodiesAdham Safieddine, Marie-Noëlle Benassy, Thomas Bonte, et al.
JNCI Cancer Spectrum|September 29, 2023
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter studyAziz Zaanan, Julie Henriques, Anthony Turpin, et al.
Nature Communications|March 2, 2021
A choreography of centrosomal mRNAs reveals a conserved localization mechanism involving active polysome transportAdham Safieddine, Emeline Coleno, Soha Salloum, et al.
Cancers|August 27, 2021
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?Melissa Frizziero, Alice Durand, Rodrigo G Taboada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2022
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial - Prodige 31 REMINET: An FFCD studyCôme Lepage, Jean-Marc Phelip, Astrid Lievre, et al.
Drug Design, Development and Therapy|September 15, 2015
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesEdward M Wolin, Barbara Jarzab, Barbro Eriksson, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
World Journal of Gastroenterology|October 30, 2019
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centresMelissa Frizziero, Xin Wang, Bipasha Chakrabarty, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 3, 2020
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Louis de Mestier, Come Lepage, Eric Baudin, et al.
Developmental Cell|August 14, 2020
A Dual Protein-mRNA Localization Screen Reveals Compartmentalized Translation and Widespread Co-translational RNA TargetingRacha Chouaib, Adham Safieddine, Xavier Pichon, et al.
Neuroendocrinology|February 3, 2017
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)Guillaume Roquin, Eric Baudin, Catherine Lombard-Bohas, et al.
Molecular Cell|October 5, 2024
Cell-cycle-dependent mRNA localization in P-bodiesAdham Safieddine, Marie-Noëlle Benassy, Thomas Bonte, et al.
JNCI Cancer Spectrum|September 29, 2023
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter studyAziz Zaanan, Julie Henriques, Anthony Turpin, et al.
Nature Communications|March 2, 2021
A choreography of centrosomal mRNAs reveals a conserved localization mechanism involving active polysome transportAdham Safieddine, Emeline Coleno, Soha Salloum, et al.
Cancers|August 27, 2021
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?Melissa Frizziero, Alice Durand, Rodrigo G Taboada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2022
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial - Prodige 31 REMINET: An FFCD studyCôme Lepage, Jean-Marc Phelip, Astrid Lievre, et al.
Drug Design, Development and Therapy|September 15, 2015
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesEdward M Wolin, Barbara Jarzab, Barbro Eriksson, et al.
Pageof 34